Literature DB >> 3361206

Duplicate thumbs: a survey of results in twenty patients.

J G Andrew1, P J Sykes.   

Abstract

20 patients were reviewed following surgery for bifid thumbs. Those patients with Wassel 1 or 2 duplications generally did well after their initial operation, but over half of those with Wassel 3 or 4 duplications required multiple procedures to achieve a satisfactory result.

Entities:  

Mesh:

Year:  1988        PMID: 3361206     DOI: 10.1016/0266-7681(88)90051-4

Source DB:  PubMed          Journal:  J Hand Surg Br        ISSN: 0266-7681


  6 in total

Review 1.  Correction of Thumb Duplication: A Systematic Review of Surgical Techniques.

Authors:  Robert Miller; Alexandre Kaempfen; Jamil Moledina; Bran Sivakumar; Gill Smith; Dariush Nikkhah
Journal:  J Hand Microsurg       Date:  2019-11-22

2.  Bifid thumb type IV in children: transferring an epiphyseal segment of the proximal phalanx with insertion of the abductor pollicis brevis tendon.

Authors:  Nguyen Ngoc Hung
Journal:  J Child Orthop       Date:  2010-10-28       Impact factor: 1.548

Review 3.  Do Patient- and Parent-reported Outcomes Measures for Children With Congenital Hand Differences Capture WHO-ICF Domains?

Authors:  Joshua M Adkinson; Rebecca S Bickham; Kevin C Chung; Jennifer F Waljee
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

4.  On-top and side-to-side plasties for thumb polydactyly.

Authors:  Noha M Al-Qattan; Mohammad M Al-Qattan
Journal:  Int J Surg Case Rep       Date:  2017-08-08

5.  A Modified Bilhaut-Cloquet Procedure for Zigzag Thumb Polydactyly Types III and IV.

Authors:  Mohammad M Al-Qattan; Abdullah E Kattan; Abdulmohsen Al-Lazzam; Adnan G Gelidan
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-12-28

6.  POSTOPERATIVE RETROSPECTIVE ANALYSIS OF THE TREATMENT OF DUPLICATED THUMB.

Authors:  Hugo Alberto Nakamoto; Frederico Faleiro Ramos; Reinaldo Borges Gonçalves; Dov Charles Goldenberg; Rolf Gemperli
Journal:  Acta Ortop Bras       Date:  2018 May-Jun       Impact factor: 0.513

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.